Cancer Center Support Grant

总体--项目摘要 堪萨斯大学癌症中心(KUCC)是一个母体癌症中心，包括： 堪萨斯医疗中心在堪萨斯城、威奇托和萨利纳的校区，堪萨斯大学在劳伦斯 通过财团协议，斯托尔斯医学研究所和堪萨斯城儿童慈善机构。 2015年，KUCC的187名成员提供了1340万美元的NCI资金和总计6120万美元的癌症资金- 相关资金，在上一个供资期间增加了1000万美元。罗伊·A·延森，医学博士，支持 通过一个强大的、全国公认的领导团队，领导KUCC。在过去的四年里取得了实质性的进展 已经扩大了与整个KUCC集水区社区的伙伴关系，促进了 招募内科科学家，加强临床研究和早期临床试验，推进 教育下一代科学家和卫生保健提供者，提高KUCC的影响力 国家科学界的研究人员。KUCC确立了四个具体目标，以确保KUCC 抗击癌症的领头羊： 1.利用独特的机构和区域资产，成为转型的领先学术机构 从实验室发现新的抗癌药物疗法； 2.提供最优环境，集中精准医学、基础科学探究、医药 发现和发展，以及行为干预，以降低癌症发病率、发病率和 死亡率； 3.在与关键利益相关者、社区倡导者和地区合作方面成为国家公认的领导者 领导开发、促进和促进采用和实施基于研究的癌症 整个KUCC集水区的预防、诊断、治疗、控制和生存实践 减轻癌症的影响；以及 4.在设想、制定和实施深思熟虑的全面战略方面发挥领导作用 教育下一代内科科学家和联合调查人员在癌症研究、治疗、 防控。 为了实现这些目标，KUCC有四个研究项目：癌症生物学、癌症控制和人口 健康、癌症预防和生存、药物发现、给药和实验治疗学。在……里面 此外，KUCC还支持临床试验办公室、五个已建立的共享资源-Biospecimen、 生物统计学和信息学、临床药理学、铅开发和优化以及转基因和 基因打靶--以及发展中的三个共享资源--细胞鉴定和病原体 筛查、健康传播研究和营养。

Overall – Project Summary The University of Kansas Cancer Center (KUCC) is a matrix cancer center that includes: the University of Kansas Medical Center campuses in Kansas City, Wichita and Salina, the University of Kansas in Lawrence and via consortium agreement, the Stowers Institute for Medical Research and Children's Mercy Kansas City. In 2015, 187 members of KUCC accounted for $13.4M of NCI funding and a total of $61.2M in overall cancer- related funding, an increase of $10M during the previous funding period. Roy A. Jensen, MD, who is supported by a strong, nationally recognized leadership team, leads KUCC. Over the last four years substantial progress has been made broadening partnerships with communities throughout the KUCC catchment area, boosting recruitment of physician-scientists, augmenting clinical research and early-phase clinical trials, advancing education for the next generation of scientists and health care providers and heightening influence for KUCC researchers in the national scientific community. KUCC has established four specific aims to ensure KUCC leads in the fight against cancer: 1. Leverage unique institutional and regional assets to become a leading academic institution for transforming discoveries from the laboratory into new anticancer drug therapies; 2. Provide the optimal environment to focus the power of precision medicine, basic science inquiry, drug discovery and development, and behavioral interventions to decrease cancer incidence, morbidity and mortality; 3. Be a nationally recognized leader in partnering with key stakeholders, community advocates and regional leaders to develop, promote, and foster the adoption and implementation of research-based cancer prevention, diagnosis, treatment, control, and survivorship practices throughout the KUCC catchment area to mitigate the impact of cancer; and 4. Provide leadership in envisioning, developing and implementing a thoughtful, comprehensive strategy to educate the next generation of physician-scientists and allied investigators in cancer research, treatment, prevention and control. To accomplish these goals KUCC has four research programs: Cancer Biology, Cancer Control and Population Health, Cancer Prevention and Survivorship, and Drug Discovery, Delivery and Experimental Therapeutics. In addition, KUCC supports the Clinical Trials Office, five established shared resources - Biospecimen, Biostatistics and Informatics, Clinical Pharmacology, Lead Development and Optimization and Transgenic and Gene-Targeting – along with three developing shared resources – Cell Authentication and Pathogen Screening, Health Communications Research and Nutrition.